<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-IM469VDI</identifier><date>2016</date><creator>Strojnik, Ksenija</creator><creator>Škof, Erik</creator><relation>documents/doc/I/URN_NBN_SI_doc-IM469VDI_001.pdf</relation><relation>documents/doc/I/URN_NBN_SI_doc-IM469VDI_001.txt</relation><format format_type="extent">42 str., 21 cm</format><format format_type="type">e-knjige</format><identifier identifier_type="COBISSID">2266747</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-IM469VDI</identifier><language>slv</language><publisher>Onkološki inštitut</publisher><source>knjige</source><rights>InC</rights><subject language_type_id="slv">BRCA</subject><subject language_type_id="slv">gen dovzetnosti za pojav raka dojk</subject><subject language_type_id="slv">kemoterapija</subject><subject language_type_id="slv">olaparib</subject><subject language_type_id="slv">rak jajčnikov</subject><subject language_type_id="slv">zaviralci PARP</subject><title>Olaparib za zdravljenje raka jajčnikov</title></Record>